Alice Kan[email protected]SequencingSequencing seeks to stay ahead of new COVID-19 surgesSequencing has been an essential tool for the development of strategies and therapeutics in the fight against COVID-19, and sequencing-based rapid and high-throughput diagnostics for COVID-19 are in development. Sequencing technology suppliers are collaborating with researchers to develop sequencing-based diagnostic tools. For example, several groups are using Illumina's next-generation sequencing (NGS) technology to develop ultrahigh-throughput COVID-19 diagnostic testing.June 7, 2020PCRVendors struggle to supply RNA extraction kits due to COVID-19SARS-CoV-2, the coronavirus responsible for the COVID-19 illness, encodes its genome in a single-stranded RNA. In vitro diagnostics of COVID-19 are done by quantitative PCR (qPCR), but first RNA must be extracted from a patient sample and reverse transcribed.May 10, 2020Page 1 of 1Top StoriesFDA ClearanceBioMĂ©rieux gets FDA 510(k) clearance, CLIA waiver approval for panelBioMĂ©rieux's Biofire Spotfire Respiratory/Sore Throat Panel has received dual FDA 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver approval.Skin CancerCastle Biosciences shares melanoma test study data at SSO 2024Artificial IntelligenceIbex presents new study data for AI-powered cancer diagnostics platformMergers & AcquisitionsAbbVie to buy Landos Biopharma for up to $212MCancerStudy sheds light on the organization of immune cells in tumors